Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J J Oudejans

Showing results (1-10 of 47) with videos related to

Pageof 5
Sort By:
Cellular Oncology : the Official Journal of the International Society for Cellular Oncology|July 23, 2005
Targeted therapies; who detects the target?G A Meijer, J J Oudejans
Journal of Clinical Pathology|December 4, 2002
Immunohistochemical classification of T cell and NK cell neoplasmsJ J Oudejans, P van der Valk
Journal of Clinical Pathology|March 1, 2003
Immunohistochemical classification of B cell neoplasmsJ J Oudejans, P van der Valk
The Journal of Pathology|April 1, 1997
Epstein-Barr virus in Hodgkin's disease: more than just an innocent bystanderJ J Oudejans, N M Jiwa, C J Meijer
Journal of Clinical Pathology|June 5, 2003
Immune escape mechanisms in ALCLJ J Oudejans, R L ten Berge, C J L M Meijer
Journal of Clinical Pathology|May 29, 2001
Anaplastic large cell lymphoma: what's in a name?R L ten Berge, J J Oudejans, D F Dukers, et al.
The American Journal of Pathology|July 31, 1999
T-cell-rich large-B-cell lymphoma (TCRBCL) as compared to diffuse large-B-cell lymphomaJ J Oudejans, D F Dukers, R L ten Berge, et al.
Critical Reviews in Oncology/Hematology|February 1, 1997
Epstein-Barr virus and its possible role in the pathogenesis of B-cell lymphomasJ J Oudejans, N M Jiwa, A J van den Brule, et al.
Histopathology|March 31, 2007
Immunohistochemical detection of nuclear survivin in NSCLC: a comparison of commercial antibodiesB Vischioni, J J Oudejans, F A E Kruyt, et al.
International Journal of Cancer|December 2, 1991
Differential activation of ras genes by point mutation in human colon cancer with metastases to either lung or liverJ J Oudejans, R J Slebos, F A Zoetmulder, et al.
Pageof 5

Showing results (1-10 of 47) with videos related to

Sort By:
Pageof 5
Cellular Oncology : the Official Journal of the International Society for Cellular Oncology|July 23, 2005
Targeted therapies; who detects the target?G A Meijer, J J Oudejans
Journal of Clinical Pathology|December 4, 2002
Immunohistochemical classification of T cell and NK cell neoplasmsJ J Oudejans, P van der Valk
Journal of Clinical Pathology|March 1, 2003
Immunohistochemical classification of B cell neoplasmsJ J Oudejans, P van der Valk
The Journal of Pathology|April 1, 1997
Epstein-Barr virus in Hodgkin's disease: more than just an innocent bystanderJ J Oudejans, N M Jiwa, C J Meijer
Journal of Clinical Pathology|June 5, 2003
Immune escape mechanisms in ALCLJ J Oudejans, R L ten Berge, C J L M Meijer
Journal of Clinical Pathology|May 29, 2001
Anaplastic large cell lymphoma: what's in a name?R L ten Berge, J J Oudejans, D F Dukers, et al.
The American Journal of Pathology|July 31, 1999
T-cell-rich large-B-cell lymphoma (TCRBCL) as compared to diffuse large-B-cell lymphomaJ J Oudejans, D F Dukers, R L ten Berge, et al.
Critical Reviews in Oncology/Hematology|February 1, 1997
Epstein-Barr virus and its possible role in the pathogenesis of B-cell lymphomasJ J Oudejans, N M Jiwa, A J van den Brule, et al.
Histopathology|March 31, 2007
Immunohistochemical detection of nuclear survivin in NSCLC: a comparison of commercial antibodiesB Vischioni, J J Oudejans, F A E Kruyt, et al.
International Journal of Cancer|December 2, 1991
Differential activation of ras genes by point mutation in human colon cancer with metastases to either lung or liverJ J Oudejans, R J Slebos, F A Zoetmulder, et al.
Pageof 5